Connecting Waterpeople

You are here

Latest wastewater data reveal drug-taking habits in over 70 European cities

  • Latest wastewater data reveal drug-taking habits in over 70 European cities

About the entity

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate.

The latest findings from the largest European project in the emerging science of wastewater analysis are presented by the Europe-wide SCORE group, in association with the EU drugs agency (EMCDDA). The project analysed wastewater in 73 European cities in 20 European countries in March 2018 to explore the drug-taking behaviours of their inhabitants. The 2018 study points to an increase in the detection of amphetamine, cocaine and MDMA in wastewater samples, compared to the 2017 figures.

From Lisbon to Athens and from Copenhagen to Madrid, the study analysed daily wastewater samples in the catchment areas of wastewater treatment plants over a one-week period. Wastewater from approximately 46 million people was analysed for traces of four illicit drugs: amphetamine, cocaine, MDMA (ecstasy) and methamphetamine.

Wastewater based epidemiology is a rapidly developing scientific discipline with the potential for monitoring close to real-time, population-level trends in illicit drug use. By sampling a known source of wastewater, such as a sewage influent to a wastewater treatment plant, scientists can now estimate the quantity of drugs used in a community by measuring the levels of illicit drugs and their metabolites excreted in urine (see motion graphic for method below).

The project analysed wastewater in 73 European cities in 20 European countries in March 2018 to explore the drug-taking behaviours of their inhabitants

The SCORE group has been conducting annual wastewater monitoring campaigns since 2011.

A total of 33 cities have participated in five or more of the eight campaigns run so far, which allows for time-trend analysis of drug consumption based on wastewater testing.

The 2018 results are released in ‘Wastewater analysis and drugs — a European multi-city study’, an updated edition in the EMCDDA Perspectives on Drugs (POD) series. The POD includes an innovative interactive map and a chart-based tool allowing the user to look at geographical and temporal patterns and to zoom in on results per city and per drug. New resources available this year include ‘Frequently asked questions’ (FAQs) on wastewater-based epidemiology as well as a motion graphic aimed at those interested in setting up wastewater monitoring activities.

2018 findings: what’s new?

The 2018 findings offer a valuable snapshot of drug use patterns in the cities involved, revealing marked geographical and temporal variations:

  • Cocaine: In cities with wastewater data for 2017 and 2018, the latest figures reveal increases in traces of cocaine, confirming the upward trend reported in 2017. Cocaine residues in wastewater were highest in western and southern European cities, particularly in cities in Belgium, the Netherlands, Spain and the UK. The analysis points to very low levels of cocaine use in the majority of eastern European cities, but the most recent data show signs of increases.
  • Amphetamine: The most recent data show that most cities reported an increase in amphetamine residues, while data from the previous seven monitoring campaigns showed no major changes in patterns observed. The loads of amphetamine detected in wastewater varied considerably across the study locations, with the highest levels reported in cities in the north and east of Europe. Amphetamine was found at much lower levels in cities in the south of Europe.
  • MDMA: The 2018 data point to increased traces of MDMA in most cities, compared with a stabilising trend in 2017. (Sharp increases of MDMA had been observed in the period 2011–16).
  • Methamphetamine: Traditionally concentrated in Czechia and Slovakia, methamphetamine now appears to be present in Cyprus, the east of Germany, Spain and northern Europe (e.g. Finland and Norway).
  • Weekly patterns: When weekly patterns of drug use were examined, cocaine and MDMA (ecstasy) levels rose sharply at weekends in most cities. Noteworthy in 2018, is that a similar pattern was observed for amphetamine (suggesting recreational use), whereas, previously, traces appeared to be more evenly distributed throughout the week. Methamphetamine loads were found to be evenly distributed over the week.

In this project, SCORE uses a standard protocol and a common quality-control exercise in all locations, making it possible to directly compare illicit drug loads in Europe over a one-week period over eight consecutive years.

The EMCDDA adopts a multi-indicator approach to drug monitoring on the principle that no single measure can provide a full picture of the drug situation. It views wastewater analysis as a valuable additional tool in its epidemiological toolkit and one which can provide timely information on a wide spectrum of substances.

Subscribe to our newsletter

Topics of interest

The data provided will be treated by iAgua Conocimiento, SL for the purpose of sending emails with updated information and occasionally on products and / or services of interest. For this we need you to check the following box to grant your consent. Remember that at any time you can exercise your rights of access, rectification and elimination of this data. You can consult all the additional and detailed information about Data Protection.